Clinical Trial Update: Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis [Phase 3]

View source ↗

Summary

This Clinical Trial Update describes a Phase 3 study evaluating the efficacy of the PET tracer Florbetaben (18F) for diagnosing cardiac AL amyloidosis. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis
• Cardiac Amyloidosis
• Transthyretin Amyloidosis

Drugs mentioned

• Florbetaben (18F) (florbetaben)

Snippet

Sponsor: Life Molecular Imaging GmbH | Conditions: Cardiac Amyloidosis, AL Amyloidosis | Phase 3 | Status: RECRUITING